5PSQ-012 Prescription of dabigatran in the elderly population

BACKGROUND: Atrial fibrillation (AF) is a common clinical problem, particularly in the elderly. Dabigatran is indicated for the prevention of stroke and systemic embolism, and the reduction of vascular mortality for patients with non-valvular atrial AF. The recommended daily dose of dabigatran is 15...

詳細記述

保存先:
書誌詳細
出版年:Eur J Hosp Pharm
主要な著者: López-Sepúlveda, R, Soto, C Valencia, Rodríguez-Hermida, F Artime, Gómez, P Nieto, Herrera, S Guijarro, Lirola, MA García, García, E Espínola, Barrera, J Cabeza
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Group 2018
主題:
Section 5: Patient safety and quality assurance
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535149/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.366
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料